Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2020

Feb 3, 2020

35221_dirs_2020-02-03_18619033-f4eb-4784-9e08-2c8ef7115d5f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2020-01-30

Reporting Person: SIROVICH MATTHEW (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-30 Common Stock X 1199383 $0.01 Acquired 1938297 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-30 Series S Warrants (right to buy) $0.01 X 1199383 Disposed 2032-06-30 Common Stock (1199383) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 792000 Indirect
Common Stock 1414904 Indirect

Footnotes

F1: Securities of PAVmed Inc. (the "Issuer") acquired as a result of the exercise of Series S Warrants of the Issuer.

F2: The Series S Warrants were subject to a limitation on exercise such that they could not be exercised if following such exercise Mr. Sirovich would beneficially own greater than 4.75% of the outstanding shares of the Issuer's common stock. Such limitation on exercise was lifted on January 23, 2019.

F3: Securities of the Issuer held directly by The Boomer Fund, L.P. ("Boomer"). Mr. Sirovich is the general partner of Boomer and may be deemed to beneficially own the securities of the Issuer held by Boomer.

F4: Securities of the Issuer held directly by the Sirovich Family Charitable Foundation (the "Sirovich Foundation"). Matthew Sirovich is a Director and President of the Sirovich Foundation and may be deemed to beneficially own the securities of the Issuer held by the Sirovich Foundation.